NCT01445509 2026-01-15
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
Clinical Trials
7 trialsNCT01744652 2023-06-07
Dasatinib and Crizotinib in Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01015222 2022-11-23
Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00717704 2020-08-05
Solid Tumors Using Ixabepilone and Dasatinib
Medstar Health Research Institute
Phase 1 Completed
NCT00099606 2011-04-19
Phase I (PH I) Mad Refractory Solid Tumor Study
Bristol-Myers Squibb
Phase 1 Completed
NCT00162214 2011-04-14
Study of Dasatinib in Patients With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Terminated
NCT00339144 2010-12-15
Study of Dasatinib (BMS-354825) in Patients With Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed